|Articles|April 30, 2004
AMO buys Pfizer's surgical ophthalmology unit
Advanced Medical Optics Inc. (AMO) brought something special to San Diegofor this week's American Society of Cataract and Refractive Surgery meeting-thesurgical ophthalmology business formerly owned by Pfizer. AMO and Pfizer on April 21 entered into a definitive agreement for AMO to acquire Pfizer's surgical ophthalmology business for $450 million in cash.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: 3 gene therapy programmes for nAMD approaching phase 3 readouts
2
FAQ: What clinicians need to know about OCU410 phase 2 ArMaDa results
3
EURETINA 2026: Real-world evidence on retinal biosimilars
4
EURETINA 2026: How a national registry is mapping inherited retinal disease in Portugal
5















